Caspases: functional significance in health and disease
项目来源
项目主持人
项目受资助机构
项目编号
立项年度
立项时间
项目级别
研究期限
受资助金额
学科
学科代码
基金类别
关键词
参与者
参与机构
By the time the project is completed we are planning:1. To establish and understand the evolutionary component of the programmed cell death (PCD) process, construct a phylogenetic caspase tree, and predict new functions of these enzymes, as well as their role in the process of oncogenesis.2. To figure out the phenotype of animals deficient in caspase-2 gene and understand the apoptotic and non-apoptotic functions of this protein.3. To obtain new important information about the role of caspase-2 in the processes of various types of PCD, its role in the detection of DNA damage and its repair. It is known that the machine regulating PCD is constantly expressed in cells, but is under the control of inhibitory factors. It is important to note that many genes and their products involved in the regulation of PCD can perform "normal" functions, not associated with death. Unfortunately, most of these functions to date has not been investigated. Therefore, the identification of genes and their products involved in the regulation of PCD and the relationship between them is an important scientific task. At the same time, the ever-increasing amount of knowledge about the mechanism of their action laid the bases for the development of new therapeutic strategies that can use as targets various links of metabolic pathways of cell death. Caspases, a family of cysteine proteases, play an important role in the initiation and development of apoptosis, the most studied mechanism of PCD. They are found in many organisms, but their role in evolution is completely unknown. As a result of this project, we expect to find out the evolutionary component of the PCD process, to build a phylogenetic caspase tree and, as far as possible, predict new functions of these enzymes. There are currently no such data and it is completely obvious that such results will correspond to the most advanced level of knowledge. These results will also help to establish the role of caspases in the cellular processes of oncogenesis.In this project, we will continue to study the properties of caspase-2. In frame of the previous project, supported by RSF, for the first time we were able to show the existence of an alternative caspase-2 activation platform, different from the PIDDosome platform described earlier. The mechanism of caspase-2 activation in the high-molecular weight complex in response to the treatment of cancer cells with the DNA damaging drug cisplatin was identified; an original method to isolate the high-molecular weight complex of caspase-2 activation was developed (a patent was obtained); cell lines were created using the CRISPR/Cas9 genome editing system, characterized by the complete absence of caspase-2 and heterozygotes of the corresponding mice were generated. In this project, after receiving homozygous mice, we expect to receive new data on the phenotype of animals deficient in the caspase-2 gene and understand both the apoptotic and non-apoptotic functions of this enzyme. Moreover, since caspase-2 can fulfill oncosuppressive functions, our results will help to establish the mechanism of this phenomenon. For the first time, we will be able to describe the role of caspase-2 in the regulation of the immune and reproductive systems of the body, as well as in cognitive function. Fundamentally important and interesting to obtain new information on the role of caspase-2, not only in apoptosis, but also other types of PCD, its role in the detection and repair of DNA damage. All expected results are new, original and correspond to the high international level.
Annotation of the results obtained in 2021During the current period, the analysis of the representation of functional groups of proteins in various suborders of rodents Sciuromorpha, Hystricomorpha, Castorimorpha, Myomorpha was carried out in order to identify unique molecular cell pathways characteristic of rodents with a long lifespan. The analysis revealed that species of the suborders Sciuromorpha, Hystricomorpha, Castorimorpha, which are characterized by a longer lifespan, are characterized by the presence of a number of proteins of the chemokine-cytokine pathway group, as well as beta-defensin proteins, which are involved in the regulation and migration of immune cells, as well as antimicrobial protection. Based on the previous data and current results, a model was formed that demonstrates significant changes in the immune system of rodents in the suborders Sciuromorpha, Hystricomorpha, Castorimorpha.To analyze the functions of caspase-2 at the level of the whole organism, we created 2 strains of mice knockout for this gene using the CRISPR/Cas9 approach. The investigation of these two strains gave a completely unexpected result. We have shown that knockout females are unable to produce offspring when crossed with any variant of the male genotype – wild-type, heterozygote, or knockout. At the same time, knockout males have the opportunity to produce offspring, both with wild-type females and heterozygous individuals. This phenotypic manifestation could be explained by the caspase-2-dependent development of the female reproductive system. An analysis of the crossing of all possible pairs from WTxWT to KO-casp2xKO-casp2 (WT is a wild-type of mice, KO-casp2 is any of the two knockout strains) showed that genotype splitting occurs according to the classical laws of inheritance. Analysis of body weight and individual organs in order to reveal the difference in the phenotype showed that, apart from visceral fat, females have no statistical differences in the weight of organs between knockout animals as compared to the wild-type. This indicated that, upon knockout of caspase-2, shifts in metabolic homeostasis could occur. Analysis of sperm and testes of males demonstrated that neither testis morphology nor sperm quality differs in knockout animals from the wild-type. Analysis of organs and hormones of the reproductive system showed that only animals with a deletion of 20 nucleotides have any difference from wild-type animals - males were characterized by an increased content of testosterone, and females by an increased weight of the uterus and ovaries. This difference could be caused by individual changes in the mouse strain due to genome editing using the CRISPR/Cas9 system.Analysis of the female sexual cycle showed that some of the knockout animals for an abnormally long time are in the same phase of the cycle, compared with wild-type animals. In this case, the motor activity of females - an indicator correlating with cycling - changed depending on the time of the day. It turned out that knockout females are less active during the day than wild-type animals. This indicated a possible imbalance in hormones. Analysis of progesterone and estradiol noted only a trend towards an increase in estradiol production and a decrease in progesterone, but this change was not statistically significant. We conducted a study on whether the studied animals can tolerate pregnancy after transferring healthy embryos to knockout mice. The results of these experiments showed that more than half of the del7/del7 knockout mice and all del20/del20 mice are unable to tolerate pregnancy. Thus, the infertility of caspase-2 knockout females was caused not only by changes in the ovary but also by the inability to endure pregnancy. Analysis of the male reproductive system showed that knockout animals do not have any pronounced differences in testes morphology or sperm quality. It should be noted that the knockout females were characterized by strong morphological changes in the ovary - at the age of 2-3 months, they were characterized by hyperplasia of the corpus luteum and a reduction or almost complete absence of oocytes in the follicles. Consequently, crossed knockout males may have offspring, unlike females. Thus, it can be concluded that caspase-2 performs a very important and specific function in the body, ensuring the correct functioning of the female reproductive system.In addition to experiments with animals, we analyzed the formation of a mitotic catastrophe and its outcome depending on the presence of the p53 protein, one of the main protectors of genome integrity. Caspase-2 is a regulator of p53 stability because can cleave the negative regulator of this protein - MDM2 ubiquitin ligase. Mitotic catastrophe is an oncosuppressive mechanism and is characterized by the formation of multi- or micronuclei in the cell after DNA damage in the G2/M phase of the cell cycle. The further fate of these cells depends on the balance of a number of proteins, including, as we assumed, the presence of p53. In a set of experiments, we showed that the treatment of HCT116 cancer cells with low doses of doxorubicin leads to the accumulation of cells in a state of mitotic catastrophe, and the absence of p53 reduces this accumulation. Moreover, under conditions of the formation of a mitotic catastrophe, the absence of p53 leads to the stimulation of autophagy, which often contributes to the survival of cells under stress conditions. Thus, it is highly probable that p53 regulates the formation of a mitotic catastrophe and the accompanying autophagy, which determines the outcome of a mitotic catastrophe, the death of a tumor cell, or its survival.During the reporting period, we continued to study the effect of inhibiting the activity of the anti-apoptotic protein Mcl-1 with the aim of elucidating the use of BH3 mimetics in the treatment of solid neoplasms. We have shown for the first time that the Bak and Bcl-xL proteins can regulate the sensitivity of tumor cells to Mcl-1 inhibitors. We also found that BH3 mimetic S63845 induced apoptosis more effectively than another Mcl-1 inhibitor, A1210477, via a Bak-dependent mechanism. We further demonstrated that the sensitivity of cancer cells correlates with low expression of the Bcl-xL protein. Moreover, acquired resistance to inhibition of Mcl-1 may be associated with increased expression of the Bcl-xL protein. In addition, low levels of Bcl-xL and high levels of Bak of both mRNA and proteins were observed in tumor tissues obtained from patients with lung adenocarcinoma. Overall, our results have shown an important role for the Bak and Bcl-xL proteins in regulating the sensitivity and resistance of tumor cells to Mcl-1 inhibition.As a result of our research, during 2021 we published 1 article in domestic and 7 articles in international journals, of which 6 in journals related to Q1. In addition, 5 invited presentations were made at conferences held in Russia. For publications supported by this grant, 4 project participants were recognized as laureates of the Moscow State University Competition in the Outstanding Articles category. One participant (A.V. Zamaraev) was awarded the RAS Gold Medal with a prize for young scientists of Russia for carrying out research included in this project.
1.Mcl-1as a"barrier"in cancer treatment:Can we target it now?
- 关键词:
- SMALL-MOLECULE INHIBITOR; ENDOPLASMIC-RETICULUM STRESS; ANTI-APOPTOTIC MCL-1; RANDOMIZED PHASE-II; OBATOCLAX MESYLATE; CELL-DEATH; PAN-BCL-2 INHIBITOR; DEPENDENT APOPTOSIS; CLINICAL ACTIVITY; MULTIPLE-MYELOMA
- Pervushin, Nikolay V.;Senichkin, Viacheslav V.;Zhivotovsky, Boris;Kopeina, Gelina S.
- 《CELL DEATH REGULATION IN HEALTH AND DISEASE - PT A》
- 2020年
- 会议
During the last two decades, the study of Mcl-1, an anti-apoptotic member of the Bcl-2 family, attracted researchers due to its important role in cancer cell survival and tumor development. The significance of Mcl-1 protein in resistance to chemotherapeutics makes it an attractive target in cancer therapy. Here, we discuss the diverse possibilities for indirect Mcl-1 inhibition through its downregulation, for example, via targeting for proteasomal degradation or blockage of translation and transcription. We also provide an overview of the direct blocking of protein-protein interactions with pro-apoptotic Bcl-2 family proteins, including examples of the most promising regulators of Mcl-1 and selective BH3-mimetics, which at present are under clinical evaluation. Moreover, several approaches for the co-targeting of Mcl-1 and other proteins (e.g., CDKs) are also presented. In addition, we highlight the broad spectrum of problems that accompanied the discovery and development of effective Mcl-1 inhibitors.
...
